Business Segments Gedeon Richter LUXEMBOURG S.E.

Stocks

End-of-day quote LUXEMBOURG S.E. Other stock markets 2026-06-16			5-day change	1st Jan Change
39.80 ^USD	-0.50%		+2.58%	+31.79%

06-16	AI in Hungary could unlock productivity gains of EUR15 billion, McKinsey says	RE
06-10	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI

Breakdown by Business Segment (HUF)

Fiscal Period: December	2021	2022	2023	2024	2025
Pharmaceutical Products
Pharmaceuticals - Women's Healthcare (WHC)	-	-	256B	286B	329B
Gross Profit	-	-	169B	193B	219B
Operating Income	-	-	39.43B	44.34B	53.06B
Pharmaceuticals - Neuropsychiatry (CNS)	-	-	206B	243B	265B
Gross Profit	-	-	204B	241B	263B
Operating Income	-	-	175B	215B	231B
Pharmaceuticals - General Medicines (GM)	-	-	227B	251B	250B
Gross Profit	-	-	122B	130B	129B
Operating Income	-	-	43.32B	39.97B	37.02B
Pharmaceuticals - Pharma Other	-	-	13.02B	11.12B	6.99B
Gross Profit	-	-	1.73B	291M	-1.71B
Operating Income	-	-	-616M	-1.68B	-3.18B
Pharmaceuticals	505B	656B	-	-	-
Total Assets	1,220B	1,412B	-	-	-
Interest Expense	-	-	-	-	-
CAPEX	-142B	-71.16B	-	-	-
Gross Profit	338B	447B	-	-	-
D&A	43.44B	46.97B	-	-	-
Operating Income	135B	152B	-	-	-
Biological Products
Pharmaceuticals - Biotechnology (BIO)	-	-	46.2B	54.01B	64.16B
Gross Profit	-	-	16.78B	20.66B	25.72B
Operating Income	-	-	-20.68B	-17.83B	-13.28B
Pharmaceutical Product Distribution
Other	7.15B	9.72B	70.87B	24.98B	25.58B
Total Assets	4.1B	22.72B	-	-	-
Interest Expense	-	-	-	-	-
CAPEX	-262M	-310M	-	-	-
Gross Profit	804M	633M	7.65B	5.43B	5.22B
D&A	199M	224M	-	-	-
Operating Income	386M	144M	-684M	1.03B	647M
Wholesale and Retail	134B	155B	-	-	-
Total Assets	71.38B	85.88B	-	-	-
Interest Expense	-	-	-	-	-
CAPEX	-595M	-104M	-	-	-
Gross Profit	10.25B	12.36B	-	-	-
D&A	1.29B	1.37B	-	-	-
Operating Income	465M	-49M	-	-	-
Eliminations	-15.79B	-17.88B	-13.16B	-12.24B	-10.58B
Total Assets	-150B	-180B	-	-	-
Interest Expense	-	-	-	-	-
CAPEX	20M	-	-	-	-
Gross Profit	-47M	19M	-324M	-515M	830M
D&A	-	-	-	-	-
Operating Income	-66M	1.38B	-324M	-515M	830M

Geographical breakdown of sales (HUF)

Fiscal Period: December	2021	2022	2023	2024	2025
Europe	263B	328B	501B	511B	551B
Total Assets	156B	199B	1,320B	1,557B	1,656B
CAPEX	-11.49B	-18.37B	-94.08B	-63.06B	-65.43B
North America	-	-	221B	255B	276B
Total Assets	-	-	3.09B	953M	975M
CAPEX	-	-	-	-1M	-
APAC	-	-	43.07B	48.62B	54.71B
Total Assets	-	-	14.62B	18.73B	15.74B
CAPEX	-	-	-344M	-436M	-890M
Latin America	17.6B	27.88B	31.68B	35.53B	38.31B
Total Assets	10.21B	20.16B	23.14B	26.23B	25.03B
CAPEX	-235M	-284M	-215M	-222M	-82M
Rest of The World	31.24B	36.5B	8.26B	6.71B	9.05B
Total Assets	14.58B	15.6B	-	-	-
CAPEX	-460M	-300M	-	-	-
EU 12 (Excluding Poland and Romania)	-	-	-	-	-
China	15.59B	21.71B	-	-	-
Total Assets	1.99B	5.06B	-	-	-
Other CIS Republics	-	-	-	-	-
Ukraine	-	-	-	-	-
Russia	-	-	-	-	-
WEU	-	-	-	-	-
Poland	-	-	-	-	-
Romania	-	-	-	-	-
Hungary	44.38B	46.62B	-	-	-
Total Assets	888B	996B	-	-	-
CAPEX	-127B	-52.07B	-	-	-
CIS (Commonwealth of Independent States)	135B	180B	-	-	-
Total Assets	70.48B	102B	-	-	-
CAPEX	-3.96B	-552M	-	-	-
United States of America	123B	162B	-	-	-
Total Assets	4.15B	2.86B	-	-	-
CAPEX	-	-	-	-	-